{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Veterans",
      "attitude",
      "depression",
      "genetic testing",
      "motivation",
      "pharmacogenomic testing",
      "risk"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "32667102",
  "DateCompleted": {
    "Year": "2020",
    "Month": "12",
    "Day": "31"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "09",
    "Day": "03"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "07",
        "Day": "15"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1002/da.23074"
    ],
    "Journal": {
      "ISSN": "1520-6394",
      "JournalIssue": {
        "Volume": "37",
        "Issue": "9",
        "PubDate": {
          "Year": "2020",
          "Month": "Sep"
        }
      },
      "Title": "Depression and anxiety",
      "ISOAbbreviation": "Depress Anxiety"
    },
    "ArticleTitle": "Attitudes on pharmacogenetic testing in psychiatric patients with treatment-resistant depression.",
    "Pagination": {
      "StartPage": "842",
      "EndPage": "850",
      "MedlinePgn": "842-850"
    },
    "Abstract": {
      "AbstractText": [
        "Novel technologies make it possible to incorporate pharmacogenetic testing into the medical management of depression. However, previous studies indicate that there may be a subset of subjects who have concerns about genetic testing and may be psychologically vulnerable. If so, pharmacogenetic testing in depressed subjects could negatively impact their mental health and undermine treatment goals.",
        "In this study, we developed a standardized instrument to assess motivations and attitudes around pharmacogenetic testing in a cohort of 170 depressed Veterans participating in a multi-center clinic trial.",
        "Testing reveals that subjects were largely positive about the use of genetic testing to guide pharmacological treatment and help plan their future. Most subjects showed only modest concerns about the impact on family, inability to cope with the results, and fear of discrimination. The severity of depression did not predict the concern expressed about negative outcomes. However, non-Caucasian subjects were more likely on average to endorse concerns about poor coping and fear of discrimination.",
        "These data indicate that while the overall risk is modest, some patients with depression may face psychosocial challenges in the context of pharmacogenetic testing. Future work should identify factors that predict distress and aim to tailor test results to different populations."
      ],
      "CopyrightInformation": "\u00a9 2020 Wiley Periodicals LLC."
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0001-6219-4945"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Mental Health Service, VA San Diego Healthcare System, San Diego, California."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Psychiatry, University of California San Diego, La Jolla, California."
          }
        ],
        "LastName": "McCarthy",
        "ForeName": "Michael J",
        "Initials": "MJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Mental Health Service, VA San Diego Healthcare System, San Diego, California."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Psychiatry, University of California San Diego, La Jolla, California."
          }
        ],
        "LastName": "Chen",
        "ForeName": "Yucui",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Mental Health Service, VA San Diego Healthcare System, San Diego, California."
          }
        ],
        "LastName": "Demodena",
        "ForeName": "Anna",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Bipolar and Depression Research Program, VA Palo Alto Healthcare System, Palo Alto, California."
          },
          {
            "Identifier": [],
            "Affiliation": "Stanford University Department of Psychiatry, Stanford, California."
          }
        ],
        "LastName": "Fisher",
        "ForeName": "Eileen",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Mental Health Service, VA San Diego Healthcare System, San Diego, California."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Psychiatry, University of California San Diego, La Jolla, California."
          }
        ],
        "LastName": "Golshan",
        "ForeName": "Shahrokh",
        "Initials": "S"
      },
      {
        "Identifier": [
          "0000-0003-4560-6180"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Bipolar and Depression Research Program, VA Palo Alto Healthcare System, Palo Alto, California."
          },
          {
            "Identifier": [],
            "Affiliation": "Stanford University Department of Psychiatry, Stanford, California."
          }
        ],
        "LastName": "Suppes",
        "ForeName": "Trisha",
        "Initials": "T"
      },
      {
        "Identifier": [
          "0000-0002-3013-2333"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Mental Health Service, VA San Diego Healthcare System, San Diego, California."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Psychiatry, University of California San Diego, La Jolla, California."
          }
        ],
        "LastName": "Kelsoe",
        "ForeName": "John R",
        "Initials": "JR"
      }
    ],
    "GrantList": [
      {
        "GrantID": "UL1 RR031980",
        "Acronym": "RR",
        "Agency": "NCRR NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "UL1 TR001442",
        "Acronym": "TR",
        "Agency": "NCATS NIH HHS",
        "Country": "United States"
      },
      {
        "Agency": "Pathway genomics",
        "Country": "International"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Depress Anxiety",
    "NlmUniqueID": "9708816",
    "ISSNLinking": "1091-4269"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Attitude"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [
        "drug therapy",
        "genetics"
      ],
      "DescriptorName": "Depressive Disorder, Treatment-Resistant"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genetic Testing"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Motivation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pharmacogenomic Testing"
    }
  ],
  "CoiStatement": "Conflict of Interest Statement. None of the authors have relevant conflicts of interests to report."
}